Hospital-Acquired Infections Diagnostics Market Size, Trends, Analysis, and Outlook By Test (Molecular, Conventional), By Infection (UTI, Pneumonia, Surgical site infection, Blood stream infections, Others), By Product (Consumables, Instruments), By Type (Blood tests, Urinalysis), by Region, Country, Segment, and Companies, 2024-2030
The global Hospital-Acquired Infections Diagnostics market size is poised to register 6.82% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Hospital-Acquired Infections Diagnostics market across By Test (Molecular, Conventional), By Infection (UTI, Pneumonia, Surgical site infection, Blood stream infections, Others), By Product (Consumables, Instruments), By Type (Blood tests, Urinalysis).
The hospital-acquired infections diagnostics market is witnessing significant growth due to the rising incidence of healthcare-associated infections (HAIs) and the increasing focus on infection prevention and control in healthcare settings. HAIs pose a significant challenge to patient safety and healthcare systems worldwide, leading to prolonged hospital stays, increased healthcare costs, and higher mortality rates. Diagnostics play a crucial role in the early detection and management of HAIs, enabling healthcare providers to implement timely interventions and prevent the spread of infectious pathogens. With advancements in molecular diagnostics, immunoassays, and rapid testing technologies, healthcare facilities are adopting comprehensive diagnostic solutions to identify pathogens responsible for HAIs such as Clostridium difficile, methicillin-resistant Staphylococcus aureus (MRSA), and multidrug-resistant gram-negative bacteria. Additionally, increased awareness of the importance of infection control measures and regulatory initiatives aimed at reducing HAIs are driving market expansion, with stakeholders investing in innovative diagnostic solutions to improve patient outcomes and enhance healthcare quality and safety.
Hospital-Acquired Infections Diagnostics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Hospital-Acquired Infections Diagnostics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Hospital-Acquired Infections Diagnostics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Hospital-Acquired Infections Diagnostics industry.
Key market trends defining the global Hospital-Acquired Infections Diagnostics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Hospital-Acquired Infections Diagnostics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Hospital-Acquired Infections Diagnostics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Hospital-Acquired Infections Diagnostics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Hospital-Acquired Infections Diagnostics industry
Leading Hospital-Acquired Infections Diagnostics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Hospital-Acquired Infections Diagnostics companies.
Hospital-Acquired Infections Diagnostics Market Study- Strategic Analysis Review
The Hospital-Acquired Infections Diagnostics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Hospital-Acquired Infections Diagnostics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Hospital-Acquired Infections Diagnostics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Hospital-Acquired Infections Diagnostics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Hospital-Acquired Infections Diagnostics market segments. Similarly, Strong end-user demand is encouraging Canadian Hospital-Acquired Infections Diagnostics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Hospital-Acquired Infections Diagnostics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Hospital-Acquired Infections Diagnostics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Hospital-Acquired Infections Diagnostics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Hospital-Acquired Infections Diagnostics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Hospital-Acquired Infections Diagnostics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Hospital-Acquired Infections Diagnostics in Asia Pacific. In particular, China, India, and South East Asian Hospital-Acquired Infections Diagnostics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Hospital-Acquired Infections Diagnostics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Hospital-Acquired Infections Diagnostics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Hospital-Acquired Infections Diagnostics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Hospital-Acquired Infections Diagnostics.
Hospital-Acquired Infections Diagnostics Market Company Profiles
The global Hospital-Acquired Infections Diagnostics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott, Becton, Dickinson and Company, BIOMЙRIEUX, Bioscience Inc, F. Hoffmann-La Roche Ltd, Hologic Inc, Meridian Bioscience Inc, QIAGEN, Siemens Healthcare Private Ltd, Thermo Fisher Scientific Inc
Recent Hospital-Acquired Infections Diagnostics Market Developments
The global Hospital-Acquired Infections Diagnostics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Hospital-Acquired Infections Diagnostics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Test
Molecular
Conventional
By Infection
UTI
Pneumonia
Surgical site infection
Blood stream infections
Others
By Product
Consumables
Instruments
By Type
Blood tests
Urinalysis
Geographical Segmentation:
Abbott
Becton, Dickinson and Company
BIOMЙRIEUX
Bioscience Inc
F. Hoffmann-La Roche Ltd
Hologic Inc
Meridian Bioscience Inc
QIAGEN
Siemens Healthcare Private Ltd
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
The hospital-acquired infections diagnostics market is witnessing significant growth due to the rising incidence of healthcare-associated infections (HAIs) and the increasing focus on infection prevention and control in healthcare settings. HAIs pose a significant challenge to patient safety and healthcare systems worldwide, leading to prolonged hospital stays, increased healthcare costs, and higher mortality rates. Diagnostics play a crucial role in the early detection and management of HAIs, enabling healthcare providers to implement timely interventions and prevent the spread of infectious pathogens. With advancements in molecular diagnostics, immunoassays, and rapid testing technologies, healthcare facilities are adopting comprehensive diagnostic solutions to identify pathogens responsible for HAIs such as Clostridium difficile, methicillin-resistant Staphylococcus aureus (MRSA), and multidrug-resistant gram-negative bacteria. Additionally, increased awareness of the importance of infection control measures and regulatory initiatives aimed at reducing HAIs are driving market expansion, with stakeholders investing in innovative diagnostic solutions to improve patient outcomes and enhance healthcare quality and safety.
Hospital-Acquired Infections Diagnostics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Hospital-Acquired Infections Diagnostics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Hospital-Acquired Infections Diagnostics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Hospital-Acquired Infections Diagnostics industry.
Key market trends defining the global Hospital-Acquired Infections Diagnostics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Hospital-Acquired Infections Diagnostics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Hospital-Acquired Infections Diagnostics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Hospital-Acquired Infections Diagnostics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Hospital-Acquired Infections Diagnostics industry
Leading Hospital-Acquired Infections Diagnostics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Hospital-Acquired Infections Diagnostics companies.
Hospital-Acquired Infections Diagnostics Market Study- Strategic Analysis Review
The Hospital-Acquired Infections Diagnostics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Hospital-Acquired Infections Diagnostics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Hospital-Acquired Infections Diagnostics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Hospital-Acquired Infections Diagnostics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Hospital-Acquired Infections Diagnostics market segments. Similarly, Strong end-user demand is encouraging Canadian Hospital-Acquired Infections Diagnostics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Hospital-Acquired Infections Diagnostics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Hospital-Acquired Infections Diagnostics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Hospital-Acquired Infections Diagnostics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Hospital-Acquired Infections Diagnostics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Hospital-Acquired Infections Diagnostics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Hospital-Acquired Infections Diagnostics in Asia Pacific. In particular, China, India, and South East Asian Hospital-Acquired Infections Diagnostics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Hospital-Acquired Infections Diagnostics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Hospital-Acquired Infections Diagnostics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Hospital-Acquired Infections Diagnostics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Hospital-Acquired Infections Diagnostics.
Hospital-Acquired Infections Diagnostics Market Company Profiles
The global Hospital-Acquired Infections Diagnostics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott, Becton, Dickinson and Company, BIOMЙRIEUX, Bioscience Inc, F. Hoffmann-La Roche Ltd, Hologic Inc, Meridian Bioscience Inc, QIAGEN, Siemens Healthcare Private Ltd, Thermo Fisher Scientific Inc
Recent Hospital-Acquired Infections Diagnostics Market Developments
The global Hospital-Acquired Infections Diagnostics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Hospital-Acquired Infections Diagnostics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Test
Molecular
Conventional
By Infection
UTI
Pneumonia
Surgical site infection
Blood stream infections
Others
By Product
Consumables
Instruments
By Type
Blood tests
Urinalysis
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Abbott
Becton, Dickinson and Company
BIOMЙRIEUX
Bioscience Inc
F. Hoffmann-La Roche Ltd
Hologic Inc
Meridian Bioscience Inc
QIAGEN
Siemens Healthcare Private Ltd
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Hospital-Acquired Infections Diagnostics Market Overview and Key Findings, 2024
1.2 Hospital-Acquired Infections Diagnostics Market Size and Growth Outlook, 2021- 2030
1.3 Hospital-Acquired Infections Diagnostics Market Growth Opportunities to 2030
1.4 Key Hospital-Acquired Infections Diagnostics Market Trends and Challenges
1.4.1 Hospital-Acquired Infections Diagnostics Market Drivers and Trends
1.4.2 Hospital-Acquired Infections Diagnostics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Hospital-Acquired Infections Diagnostics Companies
2. HOSPITAL-ACQUIRED INFECTIONS DIAGNOSTICS MARKET SIZE OUTLOOK TO 2030
2.1 Hospital-Acquired Infections Diagnostics Market Size Outlook, USD Million, 2021- 2030
2.2 Hospital-Acquired Infections Diagnostics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. HOSPITAL-ACQUIRED INFECTIONS DIAGNOSTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. HOSPITAL-ACQUIRED INFECTIONS DIAGNOSTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Test
Molecular
Conventional
By Infection
UTI
Pneumonia
Surgical site infection
Blood stream infections
Others
By Product
Consumables
Instruments
By Type
Blood tests
Urinalysis
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Hospital-Acquired Infections Diagnostics Market, 2025
5.2 Asia Pacific Hospital-Acquired Infections Diagnostics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Hospital-Acquired Infections Diagnostics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Hospital-Acquired Infections Diagnostics Market, 2025
5.5 Europe Hospital-Acquired Infections Diagnostics Market Size Outlook by Type, 2021- 2030
5.6 Europe Hospital-Acquired Infections Diagnostics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Hospital-Acquired Infections Diagnostics Market, 2025
5.8 North America Hospital-Acquired Infections Diagnostics Market Size Outlook by Type, 2021- 2030
5.9 North America Hospital-Acquired Infections Diagnostics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Hospital-Acquired Infections Diagnostics Market, 2025
5.11 South America Pacific Hospital-Acquired Infections Diagnostics Market Size Outlook by Type, 2021- 2030
5.12 South America Hospital-Acquired Infections Diagnostics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Hospital-Acquired Infections Diagnostics Market, 2025
5.14 Middle East Africa Hospital-Acquired Infections Diagnostics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Hospital-Acquired Infections Diagnostics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Hospital-Acquired Infections Diagnostics Market Size Outlook and Revenue Growth Forecasts
6.2 US Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
7. HOSPITAL-ACQUIRED INFECTIONS DIAGNOSTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. HOSPITAL-ACQUIRED INFECTIONS DIAGNOSTICS COMPANY PROFILES
8.1 Profiles of Leading Hospital-Acquired Infections Diagnostics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott
Becton, Dickinson and Company
BIOMЙRIEUX
Bioscience Inc
F. Hoffmann-La Roche Ltd
Hologic Inc
Meridian Bioscience Inc
QIAGEN
Siemens Healthcare Private Ltd
Thermo Fisher Scientific Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Hospital-Acquired Infections Diagnostics Market Overview and Key Findings, 2024
1.2 Hospital-Acquired Infections Diagnostics Market Size and Growth Outlook, 2021- 2030
1.3 Hospital-Acquired Infections Diagnostics Market Growth Opportunities to 2030
1.4 Key Hospital-Acquired Infections Diagnostics Market Trends and Challenges
1.4.1 Hospital-Acquired Infections Diagnostics Market Drivers and Trends
1.4.2 Hospital-Acquired Infections Diagnostics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Hospital-Acquired Infections Diagnostics Companies
2. HOSPITAL-ACQUIRED INFECTIONS DIAGNOSTICS MARKET SIZE OUTLOOK TO 2030
2.1 Hospital-Acquired Infections Diagnostics Market Size Outlook, USD Million, 2021- 2030
2.2 Hospital-Acquired Infections Diagnostics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. HOSPITAL-ACQUIRED INFECTIONS DIAGNOSTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. HOSPITAL-ACQUIRED INFECTIONS DIAGNOSTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Test
Molecular
Conventional
By Infection
UTI
Pneumonia
Surgical site infection
Blood stream infections
Others
By Product
Consumables
Instruments
By Type
Blood tests
Urinalysis
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Hospital-Acquired Infections Diagnostics Market, 2025
5.2 Asia Pacific Hospital-Acquired Infections Diagnostics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Hospital-Acquired Infections Diagnostics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Hospital-Acquired Infections Diagnostics Market, 2025
5.5 Europe Hospital-Acquired Infections Diagnostics Market Size Outlook by Type, 2021- 2030
5.6 Europe Hospital-Acquired Infections Diagnostics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Hospital-Acquired Infections Diagnostics Market, 2025
5.8 North America Hospital-Acquired Infections Diagnostics Market Size Outlook by Type, 2021- 2030
5.9 North America Hospital-Acquired Infections Diagnostics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Hospital-Acquired Infections Diagnostics Market, 2025
5.11 South America Pacific Hospital-Acquired Infections Diagnostics Market Size Outlook by Type, 2021- 2030
5.12 South America Hospital-Acquired Infections Diagnostics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Hospital-Acquired Infections Diagnostics Market, 2025
5.14 Middle East Africa Hospital-Acquired Infections Diagnostics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Hospital-Acquired Infections Diagnostics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Hospital-Acquired Infections Diagnostics Market Size Outlook and Revenue Growth Forecasts
6.2 US Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Hospital-Acquired Infections Diagnostics Industry Drivers and Opportunities
7. HOSPITAL-ACQUIRED INFECTIONS DIAGNOSTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. HOSPITAL-ACQUIRED INFECTIONS DIAGNOSTICS COMPANY PROFILES
8.1 Profiles of Leading Hospital-Acquired Infections Diagnostics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott
Becton, Dickinson and Company
BIOMЙRIEUX
Bioscience Inc
F. Hoffmann-La Roche Ltd
Hologic Inc
Meridian Bioscience Inc
QIAGEN
Siemens Healthcare Private Ltd
Thermo Fisher Scientific Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
